NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Key Developments

• On February 01, 2024, Aesthetic Management Partners (AMP), a state-of-the-art medical aesthetic equipment provider, announced the launch of Plasmage, the first fractional plasma device on the market that gives providers precise control over crepey skin, wrinkles, and delicate skin on the face and body, as well as a variety of dermatological issues such as Xanthelasma, skin tags, and fibromas
• On January 18, 2024, Empower Aesthetics, a medical aesthetics platform, announced a partnership with DermaTouch RN, a leading medical aesthetic practice with locations in Houston and San Antonio, Texas, and AW Skin Co., a well-known medical spa and wellness center with three locations in Cool Springs, Franklin, and Murfreesboro, Tennessee.
• In January 2021, Candela, a global leader in medical aesthetic devices, announced the launch of the Frax Pro system. The U.S. Food and Drug Administration (FDA)-cleared, non-ablative fractional device is the first to offer dual-depth skin resurfacing using both the Frax 1550 and the revolutionary Frax 1940 applicators. The two modalities target separate skin layers, promoting the production of new collagen and revealing smoother, more radiant skin.
• In October 2020, BTL, the company behind the revolutionary EMSCULPT technology, announced the launch of EMSCULPT NEO, the first U.S. FDA-approved procedure to eliminate fat cells non-invasively by combining specially designed radio frequency heating and high-intensity focused electromagnetic waves in a single therapy.